Norinchukin Bank’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Buy |
18,669
+2,004
| +12% | +$55.3K | 0.01% | 506 |
|
|
2025
Q1 | $472K | Buy |
16,665
+2,103
| +14% | +$59.6K | 0.01% | 498 |
|
|
2024
Q4 | $605K | Sell |
14,562
-2,457
| -14% | -$102K | 0.01% | 454 |
|
|
2024
Q3 | $1.14M | Buy |
17,019
+2,356
| +16% | +$157K | 0.03% | 323 |
|
|
2024
Q2 | $1.74M | Buy |
14,663
+623
| +4% | +$74K | 0.05% | 204 |
|
|
2024
Q1 | $1.5M | Sell |
14,040
-282
| -2% | -$30.1K | 0.04% | 237 |
|
|
2023
Q4 | $1.42M | Sell |
14,322
-1,086
| -7% | -$108K | 0.03% | 237 |
|
|
2023
Q3 | $1.59M | Sell |
15,408
-4,377
| -22% | -$452K | 0.04% | 221 |
|
|
2023
Q2 | $2.4M | Sell |
19,785
-4,954
| -20% | -$602K | 0.04% | 277 |
|
|
2023
Q1 | $3.8M | Buy |
24,739
+678
| +3% | +$104K | 0.07% | 158 |
|
|
2022
Q4 | $4.32M | Sell |
24,061
-4,364
| -15% | -$784K | 0.09% | 138 |
|
|
2022
Q3 | $3.36M | Buy |
28,425
+1,506
| +6% | +$178K | 0.07% | 173 |
|
|
2022
Q2 | $3.85M | Sell |
26,919
-9,524
| -26% | -$1.36M | 0.08% | 154 |
|
|
2022
Q1 | $6.28M | Buy |
36,443
+3,697
| +11% | +$637K | 0.08% | 138 |
|
|
2021
Q4 | $8.32M | Sell |
32,746
-2,128
| -6% | -$540K | 0.1% | 114 |
|
|
2021
Q3 | $13.4M | Buy |
34,874
+30,260
| +656% | +$11.6M | 0.19% | 86 |
|
|
2021
Q2 | $1.08M | Buy |
4,614
+710
| +18% | +$167K | 0.02% | 417 |
|
|
2021
Q1 | $511K | Buy |
3,904
+1,223
| +46% | +$160K | 0.01% | 490 |
|
|
2020
Q4 | $280K | Buy |
+2,681
| New | +$280K | ﹤0.01% | 509 |
|